Far-IR Emitted by Compression Stockings for Cellulitis Treatment

September 4, 2011 updated by: Edileia Bagatin, Federal University of São Paulo

Randomized and Controlled Study About Efficacy and Safety of Far-Infra Red Radiation Emitted by Compression Stockings for Cellulitis Treatment

This is a randomized and controlled study to investigate if the far-IR radiation emitted by compression stockings fabric may be effective and safe as adjuvant treatment for cellulitis that affects the majority of women after puberty.

The investigators expect that the far-IR effects on superficial microcirculation,deep dermis and subcutaneous fat may attenuate the clinical aspect of cellulitis.

Study Overview

Detailed Description

Cellulitis is a sex-specific, anatomic and normal condition affecting women after puberty.The main clinical aspect is the irregularity on skin surface which is classified in 4 grades, 0 to III, according to Nurenberg classification, 1978.

It is a multifactorial condition, involving: herniation of subcutaneous fat into deep dermis; vertical fibrous septum from fatty tissue to dermis; alterations in microcirculation; hormonal and inflammatory factors Clinical evaluation is very difficult and the best methods are: high resolution ultrasound and magnetic resonance.

There is no effective management. Many devices have been introduced to treat that aesthetic condition which causes a great discomfort to women. There are few controlled studies with high level methodology and consistent conclusions.

The far-IR radiation can be obtained by low energy emitting devices and its main effects are the interaction with water and temperature increase. This method had already shown efficacy for circulation system disorders and wound healing by activation of TGF-beta and fibroblasts.

Our aim is to evaluate the benefits of far-IR for cellulitis control.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Signed Consent Form
  • Healthy women
  • Age: 25 to 40 years
  • Presence of cellulitis - II or III
  • No treatment for cellulitis in the last 6 months

Exclusion Criteria:

  • Pregnancy
  • Vascular disease
  • Psychiatric disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Stockings side one
This side of the compression stockings is just the fabric (placebo).
This side of compression stocking without far-IR radiation will be used by subjects, during the day, for six hours a day, during 90 days.
Active Comparator: Stocking side two
This side of compression stocking emits far-IR radiation.
The far-IR side of compression stocking will be used by subjects, during the day, for six hours a day, during 90 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in ultra-sound images
Time Frame: 0, 30, 60 and 90 days
High resolution ultra-sound (DemaScan, Cortex Technology, Denmark)is used to measure dermis density and thickness and distance between dermis and fatty tissue in the most evident two areas with cellulitis(thighs and buttocks)
0, 30, 60 and 90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Cellulitis clinical grade
Time Frame: 0, 30, 60 and 90 days

Main investigator evaluates the clinical aspect of cellulitis, i.e., the level of irregularity of skin surface, according to Nuremberg and Müller classification in four grades:

0: no alterations I: alterations only visible by pinching the skin or contracting the muscles II: skin orange or padded aspect is visible when the woman stands up or by pinching the skin or contracting the muscles III: the same alterations of II associated to skin elevations and nodulations

0, 30, 60 and 90 days
Subject evaluation
Time Frame: day 90th
Study subjects will give their opinion about modification on cellulitis appearance using a 5-point scale: much worse; worse; no change; better; much better
day 90th
Changes in Anthropometric measures
Time Frame: 0, 30, 60 and 90 days
The circumference of thighs, hip and waist are measured in standardized points
0, 30, 60 and 90 days
Changes in Photographies
Time Frame: 0, 30, 60 and 90 days
By using the OMNIA device standardized photos are taken in three positions: front buttocks and side view of thighs
0, 30, 60 and 90 days
Changes in Skin viscoelasticity
Time Frame: 0, 30, 60 and 90 days
Skin elasticity is measured by suction with the Cutometer device(Courage&Khazaka, Germany) in the most evident two areas with cellulitis(thighs and buttocks)
0, 30, 60 and 90 days
Changes in DLQI scores
Time Frame: 0 and 90 days
The application of the quality of life generic questionnaire named Dermatology Life Quality Index or DLQI(Finlay, 1994), version DLQI-Brasil (Ferraz, 2006) will be used to evaluate the impact of cellulitis and its treatment on women´s life
0 and 90 days
Occurence of adverse events
Time Frame: 30, 60 and 90 days
Report and/or observation of side effects,such as discomfort, difficulty to use the stockings or any distress will be registered
30, 60 and 90 days
Occurence of venous insufficiency signs
Time Frame: 30, 60 and 90 days
Symptoms and signals of venous insufficiency such as fatigue, swelling, burning will be evaluate by a five-point scale:0=none; 1 = slight; 2 = slight to moderate; 3 = moderate to severe; 4 = severe; 5 = unbearable
30, 60 and 90 days
Changes in Colour eco-doppler
Time Frame: 0 and 90 days
Superficial and deep venous systems will be evaluate before and at the end of the study by colour eco-doppler
0 and 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Edileia Bagatin, M.D., PhD, Universidade Federal de Sao Paulo, Brasil

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Anticipated)

November 1, 2011

Study Completion (Anticipated)

March 1, 2012

Study Registration Dates

First Submitted

August 28, 2011

First Submitted That Met QC Criteria

September 4, 2011

First Posted (Estimate)

September 7, 2011

Study Record Updates

Last Update Posted (Estimate)

September 7, 2011

Last Update Submitted That Met QC Criteria

September 4, 2011

Last Verified

September 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • SIGVARIS
  • SigvarisUnifesp (Other Grant/Funding Number: Sigvaris do Brasil)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on No far-IR compression stockings

Subscribe